Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease

JAMA

Volumn 298, Issue 1, 2007, Pages 41-48

  Butman, John A ^a   Kim, H Jeffrey ^b   Baggenstos, Martin ^c   Ammerman, Joshua M ^c   Dambrosia, James ^c   Patsalides, Athos ^a   Patronas, Nicholas J ^a   Oldfield, Edward H ^c   Lonser, Russell R ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EAR TUMOR; ENDOLYMPHATIC SAC TUMOR; FEMALE; HUMAN; MALE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; VON HIPPEL LINDAU DISEASE; AUDIOMETRY; BLEEDING; EDEMA; ENDOLYMPHATIC SAC; HEARING LOSS; MIDDLE AGED;

ADOLESCENT; ADULT; AUDIOMETRY; EAR NEOPLASMS; EDEMA; ENDOLYMPHATIC SAC; FEMALE; HEARING LOSS; HEMORRHAGE; HIPPEL-LINDAU DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34347402240     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.298.1.41     Document Type: Article

References (26)

1. Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin: a clinicopathologic study of 20 cases. Cancer. 1989;64(11):2292-2302.
2. Lonser RR, Kim HJ, Butman JA, Vortmeyer AO, Choo D, Oldfield E. Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med. 2004;350(24): 2481-2486.
3. Manski TJ, Heffner DK, Glenn GM, et al. Endolymphatic sac tumors: a source of morbid hearing loss in von Hippel-Lindau disease. JAMA. 1997;277(18):1461-1466.
4. Choo D, Shotland L, Mastroianni M, et al. Endolymphatic sac tumors in von Hippel-Lindau disease. J Neurosurg. 2004;100(3):480-487.
5. Kim HJ, Butman JA, Brewer C, et al. Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease. J Neurosurg. 2005;102(3):503-512.
6. Neumann HP, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome. Lancet. 1991;337 (8749):1052-1054.
7. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260(5112):1317-1320.
8. Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet. 2003;361(9374):2059-2067.
9. Wait SD, Vortmeyer AO, Lonser RR, et al. Somatic mutations in VHL germline deletion kindred correlate with mild phenotype. Ann Neurol. 2004;55(2):236-240.
10. Richard S, Campello C, Taillandier L, Parker F, Resche F. Haemangioblastoma of the central nervous system in von Hippel-Lindau disease: French VHL Study Group. J Intern Med. 1998;243(6):547-553.
11. Linehan WM, Lerman MI, Zbar B. Identification of the von Hippel-Lindau (VHL) gene: its role in renal cancer. JAMA. 1995;273(7):564-570.
12. Libutti SK, Choyke PL, Alexander HR, et al. Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease. Surgery. 2000;128(6):1022-1027.
13. Vortmeyer AO, Choo D, Pack SD, Oldfield E, von Zhuang Z. Hippel-Lindau disease gene alterations associated with endolymphatic sac tumor. J Natl Cancer Inst. 1997;89(13):970-972.
14. Vortmeyer AO, Choo D, Pack S, Oldfield E, Zhuang Z. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease. Neurology. 2000;55(3):460.
15. Megerian CA, McKenna MJ, Nuss RC, et al. Endolymphatic sac tumors. Laryngoscope. 1995;105(8, pt 1):801-808.
16. Megerian CA, Haynes DS, Poe DS, Choo DI, Keriakas TJ, Glasscock ME III. Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome. Otol Neurotol. 2002;23 (3):378-387.
17. Schuknecht HF, Belal AA. The utriculoendolymphatic valve: its functional significance. J Laryngol Otol. 1975;89(10):985-996.
18. Thomassin JM, Roche PH, Braccini F, Epron JP, Pellet W. Endolymphatic sac tumors [published in French]. Ann Otolaryngol Chir Cervicofac. 2000;117(5):274-280.
19. Hansen MR, Luxford WM. Surgical outcomes in patients with endolymphatic sac tumors. Laryngoscope. 2004;114(8):1470-1474.
20. Rodrigues S, Fagan P, Turner J. Endolymphatic sac tumors. Otol Neurotol. 2004;25(4):599-603.
21. Gaeta M, Blandino A, Minutoli F, Pandolfo I. Sudden unilateral deafness with endolymphatic sac adenocarcinoma: MRI. Neuroradiology. 1999;41(10):799-801.
22. Lonser RR, Vortmeyer AO, Butman JA, et al. Edema is a precursor to central nervous system peritumoral cyst formation. Ann Neurol. 2005;58(3):392-399.
23. Walther MM, Lubensky IA, Venzon D, Zbar B, Linehan WM. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol. 1995;154(6):2010-2014.
24. Lonser RR, Weil RJ, Wanebo JE, DeVroom HL, Oldfield EH. Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg. 2003;98(1):106-116.
25. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg. 2003;98(1):82-94.
26. Libutti SK, Choyke PL, Bartlett DL, et al. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. Surgery. 1998;124(6):1153-1159.